2025-08-21T16:07:53-05:00 2024-12-31 223604710 JAMES M WOOD CPA 603B OMNI DRIVE HILLSBOROUGH NJ 08844 990 2024-01-01 311405490 THE PARENT PROJECT FOR MUSCULAR DYSTROPHY RESEARCH INC PARE 2012508440 1012 14TH STREET NW 500 WASHINGTON DC 20005 PATRICIA A FURLONG FOUNDING PRESIDENT/CEO 2012508440 2025-07-28 1 0 JAMES M WOOD P00310420 9084311700 2025-07-28 X 2024 2025-03-06 01:10:19Z PATRICIA A FURLONG 1012 14TH STREET NW 500 WASHINGTON DC 20005 15003956 0 X WWW.PARENTPROJECTMD.ORG X 1997 OH END DUCHENNE MUSCULAR DYSTROPHY THROUGH RESEARCH, ADVOCACY, EDUCATION, & OPTIMAL MEDICAL CARE. 16 16 27 500 0 0 12660929 10008956 1210969 2234268 88569 150586 -79382 1917951 13881085 14311761 2560127 2650583 0 0 3699580 4089108 0 0 662951 5852779 6141711 12112486 12881402 1768599 1430359 10440900 12567424 634715 1109314 9806185 11458110 X THE PARENT PROJECT MUSCULAR DYSTROPHY (PPMD) FIGHTS TO END DUCHENNE. WE ACCELERATE RESEARCH, RAISE OUR VOICES TO IMPACT POLICY, DEMAND OPTIMAL CARE FOR EVERY SINGLE FAMILY, AND STRIVE TO ENSURE ACCESS TO APPROVED THERAPIES. 0 0 7260936 2443083 4432545 RESEARCHPPMD'S RESEARCH PROGRAM IDENTIFIES AND FUNDS THE MOST PROMISING NEAR- AND LONG-TERM THERAPEUTIC STRATEGIES FOR DUCHENNE AND BECKER MUSCULAR DYSTROPHY. WE INVEST ACROSS THE DEVELOPMENT PIPELINE-FROM BASIC SCIENCE TO CLINICAL APPLICATION-WHILE ACTIVELY STIMULATING NEW RESEARCH TO KEEP THE THERAPEUTIC PIPELINE ROBUST. THROUGH INITIATIVES LIKE THE DUCHENNE DRUG DEVELOPMENT ROUNDTABLE, WE FOSTER PRE-COMPETITIVE INDUSTRY COLLABORATION TO HARMONIZE THE CLINICAL TRIAL LANDSCAPE AND ACCELERATE PROGRESS.IN ADDITION TO FUNDING ACADEMIC AND PRE-CLINICAL RESEARCH, OUR VENTURE PATHWAYS PROGRAM INVESTS IN EARLY-STAGE BIOPHARMACEUTICAL COMPANIES TO DRIVE THE DEVELOPMENT OF NOVEL TREATMENTS FOR DUCHENNE AND BECKER MUSCULAR DYSTROPHY.THE DUCHENNE REGISTRYESTABLISHED IN 2007, THE DUCHENNE REGISTRY IS THE LARGEST PATIENT-REPORTED DATA REPOSITORY FOR INDIVIDUALS LIVING WITH DUCHENNE AND BECKER MUSCULAR DYSTROPHY AND CARRIER FEMALES. WITH PARTICIPATION FROM OVER 6,000 FAMILIES WORLDWIDE, THE REGISTRY HELPS BRIDGE INFORMATION GAPS BETWEEN FAMILIES, CLINICIANS, AND RESEARCHERS. IT HAS CONTRIBUTED TO 14 PEER-REVIEWED PUBLICATIONS AND SUPPORTED OVER 85 CLINICAL TRIALS THROUGH TARGETED OUTREACH.PPMD ALSO MANAGES COMPLEMENTARY INITIATIVES:-THE DUCHENNE OUTCOMES RESEARCH INTERCHANGE (THE INTERCHANGE) AGGREGATES PATIENT- AND CLINICIAN-REPORTED DATA TO PROVIDE A COMPREHENSIVE VIEW OF THE LIVED EXPERIENCE OF DUCHENNE, SUPPORTING REAL-WORLD EVIDENCE GENERATION.- THE ELECTRONIC HEALTH RECORD (EHR) STUDY EXTRACTS DE-IDENTIFIED CLINICAL DATA FROM CERTIFIED DUCHENNE CARE CENTERS TO IMPROVE CARE AND INFORM RESEARCH WITHOUT ADDING BURDEN TO PATIENTS OR PROVIDERS.CAREPPMD'S CARE PROGRAM ENSURES INDIVIDUALS WITH DUCHENNE HAVE ACCESS TO EXPERT CLINICAL TEAMS, APPROVED THERAPIES, AND COMPREHENSIVE MULTIDISCIPLINARY CARE ACROSS THEIR LIFESPAN. WE IDENTIFY GAPS IN CARE AND WORK COLLABORATIVELY WITH GLOBAL HEALTHCARE PROVIDERS TO CLOSE THOSE GAPS AND IMPROVE OUTCOMES.OUR CERTIFIED DUCHENNE CARE CENTER (CDCC) PROGRAM CERTIFIES CARE CENTERS THAT MEET RIGOROUS STANDARDS ALIGNED WITH THE DUCHENNE CARE GUIDELINES. THESE CENTERS COMMIT TO DELIVERING CONSISTENT, HIGH-QUALITY CARE BASED ON BEST PRACTICES. 2863541 7500 EDUCATIONPPMD'S EDUCATION INITIATIVES EQUIP FAMILIES, HEALTHCARE PROVIDERS, AND THE BROADER COMMUNITY WITH THE INFORMATION NEEDED TO NAVIGATE DUCHENNE CARE ACROSS ALL STAGES OF THE DISORDER. WE PARTNER WITH CLINICAL AND SCIENTIFIC EXPERTS TO DEVELOP ACCURATE, ACCESSIBLE RESOURCES AND SHARE THEM BROADLY. WE ALSO COLLABORATE WITH DOMESTIC AND INTERNATIONAL ORGANIZATIONS TO ENSURE EDUCATIONAL MATERIALS REACH GLOBAL AUDIENCES.ENGAGEMENTPPMD FOSTERS A STRONG, INFORMED, AND CONNECTED COMMUNITY. EACH SUMMER, WE HOST THE WORLD'S LARGEST DUCHENNE CONFERENCE, BRINGING TOGETHER FAMILIES, CLINICIANS, RESEARCHERS, AND INDUSTRY PARTNERS TO SHARE UPDATES AND BUILD CONNECTIONS.THROUGHOUT THE YEAR, WE OFFER VIRTUAL AND IN-PERSON GATHERINGS FOR SUBGROUPS INCLUDING DUCHENNE CARRIERS, SIBLINGS, DADS, GRANDPARENTS, AND NEWLY DIAGNOSED FAMILIES.THROUGH PPMD TOGETHER, WE ALSO PROVIDE PERSONALIZED ONE-ON-ONE VIRTUAL SUPPORT TO HELP FAMILIES NAVIGATE THEIR INDIVIDUAL CHALLENGES. 1250344 200000 ADVOCACYPPMD LEADS FEDERAL AND STATE-LEVEL ADVOCACY TO IMPROVE ACCESS TO CARE, ACCELERATE THERAPEUTIC DEVELOPMENT, AND ENSURE REGULATORY FRAMEWORKS SUPPORT THE DUCHENNE COMMUNITY. WE PROVIDE ADVOCATES WITH THE TOOLS AND INFORMATION NEEDED TO ENGAGE POLICYMAKERS AND BUILD CONGRESSIONAL CHAMPIONS.WE ALSO SPEARHEAD EFFORTS TO EXPAND NEWBORN SCREENING FOR DUCHENNE, ENSURING EARLY DIAGNOSIS AND ACCESS TO INTERVENTIONS. 11374821 1 1 0 1 0 0 0 0 0 0 1 1 1 0 1 0 1 0 0 0 1 1 0 0 1 0 0 1 0 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 44 0 1 27 1 0 0 0 0 0 0 0 0 0 0 0 0 X 16 16 1 0 0 0 0 0 0 1 0 0 0 1 1 1 1 1 1 1 1 0 AL CA FL GA HI IL KS KY MA MD MI MN MS NC NH NJ NM NY OR PA RI SC TN VA WI WV X X THE ORGANIZATION 2012508440 1012 14TH STREET NW 500 WASHINGTON DC 20005 GRETCHEN EGNER BOARD CHAIRMAN 8.00 X X 0 0 0 ALPA KHUSHALANI VICE CHAIR 8.00 X X 0 0 0 DAWN REZKALLA TREASURER 6.00 X X 0 0 0 DEANNE FRIAR SECRETARY 6.00 X X 0 0 0 DAVID N HOFSTEIN EXECUTIVE COMMITTEE 6.00 X 0 0 0 SUE APKON DIRECTOR 2.00 X 0 0 0 JEFFREY BIGELOW DIRECTOR 2.00 X 0 0 0 MARU CHAPUR DIRECTOR 2.00 X 0 0 0 TIMOTHY CRIPE DIRECTOR 2.00 X 0 0 0 MICHELLE FURLONG DIRECTOR 2.00 X 0 0 0 LANCE HESTER DIRECTOR 2.00 X 0 0 0 SUSAN HUANG DIRECTOR 2.00 X 0 0 0 JOHN KILLIAN DIRECTOR 2.00 X 0 0 0 RICHARD KLEIN DIRECTOR 2.00 X 0 0 0 SCOTT PERRIN DIRECTOR 2.00 X 0 0 0 COLIN RENSCH DIRECTOR 2.00 X 0 0 0 PATRICIA A FURLONG PRESIDENT AND CEO 40.00 X 370075 0 13694 KAYLAN MOITOSO CHIEF BUSINESS OFFICER 40.00 X 293650 0 9025 JODI WOLFF CHIEF PROGRAM OFFICER 40.00 X 194569 0 12395 ANN MARTIN VICE PRESIDENT, COMMUNITY RESEARCH & GENETIC SERV. 40.00 X 176600 0 16829 RACHEL SCHRADER VICE PRESIDENT, CLINICAL CARE & EDUCATION 40.00 X 174800 0 33557 1209694 0 85500 13 0 1 0 OMNI HOTELS 1500 MASTERS BLVD DAVENPORT FL 33896 MEETING AND CONFERENCE SERVICES 978891 SANIBEL HARBOUR MARRIOTT RESORT AND SPA 17260 HARBOUR POINTE DR FT MYERS FL 33908 MEETING AND CONFERENCE SERVICES 413775 FAEGRE DRINKER BIDDLE & REATH LLP 75 REMITTANCE DRIVE DEPT 6952 CHICAGO IL 60675 LEGAL AND REGULATORY CONSULTING 372956 UHS PREMIUM BILLING PO BOX 94017 PALATINE IL 60094 HEALTH INSURANCE 311634 ALL COLORS 425 RARITAN AVENUE HIGHLAND PARK NJ 08904 MATERIALS SUPPLIER, SHIPPING, AND STORAG 277424 16 3216030 6792926 10008956 CONFERENCE INCOME 900099 830046 830046 OTHER MEETINGS AND CONFERENCES 900099 720300 720300 FEES FOR SERVICE 900099 683922 683922 2234268 149903 149903 305688 305005 683 683 683 106864 3216030 387190 -280326 -280326 REVENUE SHARING 900099 2193277 2193277 OTHER 900099 4849 4849 RECOVERY OF PREVIOUSLY AWARDED GR 900099 151 151 2198277 14311761 4432545 0 -129740 X 2464612 2464612 185971 185971 370075 314564 18504 37007 3045805 2582039 192317 271449 145866 122338 10502 13026 287801 241342 20755 25704 239561 200920 17248 21393 153709 86114 67177 418 22000 22000 1369143 1146523 174370 48250 51895 49892 2003 49199 6065 42943 191 82826 78170 2570 2086 535207 512763 5755 16689 244273 238835 5438 15473 13121 955 1397 21538 14644 5335 1559 ANNUAL CONFERENCE 1432211 1432211 0 0 PROGRAM SUPPLIES 754944 754944 0 0 MEALS 562431 557779 3313 1339 TECHNOLOGY 329031 103013 173839 52179 517831 268961 80609 168261 12881402 11374821 843630 662951 3303990 5201236 1500476 1500774 1565673 940770 252548 550137 65513 87886 367666 474736 121064 106797 20361 14267 282716 505462 2113362 2357590 850479 850479 118116 84087 10440900 12567424 435449 458828 102502 556646 17450 96764 76390 634715 1109314 X 7453058 9034708 2353127 2423402 9806185 11458110 10440900 12567424 1430359 221566 0 X X 0 1 X 1 0 X 8889998 9127402 9959415 12802680 10008956 50788451 8889998 9127402 9959415 12802680 10008956 50788451 18497581 32290870 203 49538 9584 88182 149903 297410 329826 329826 51415687 5132971 0.62800 0.63100 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 18121 70000 88121 12793281 12881402 794070 198518 0 0 542168 701882 755624 794070 2793744 4190616 50000 107134 110148 88121 355403 135542 175471 188906 198518 698437 1047656 16400 27134 30148 18121 91803 105045 90778 14267 16019 16019 0 14267 REAL ESTATE INVESTMENT TRUST 398582 F U.S. TREASURY BONDS 1959008 F 2357590 AGREEMENT FOR FUTURE EQUITY 850479 C 850479 OPERATING LEASE LIABILITIES 76390 76390 14533327 221566 221566 14311761 0 14311761 12881402 0 12881402 0 12881402 0 NORTH AMERICA - CANADA AND MEXICO, BUT NOT THE UNITED STATES 0 0 GRANTS TO RECIPIENTS LOCATED IN REGION 152910 EUROPE (INCLUDING ICELAND & GREENLAND) 0 0 GRANTS TO RECIPIENTS LOCATED IN REGION 33061 0 0 0 0 0 0 185971 0 185971 NORTH AMERICA - CANADA AND MEXICO, BUT NOT THE UNITED STATES CARE FELLOWSHIP 80000 WIRE TRANSFER 0 EUROPE (INCLUDING ICELAND & GREENLAND) RESEARCH - BRAIN PROJECT AND PROTEIN MAPPING PROJECT 33061 WIRE TRANSFER 0 NORTH AMERICA RESEARCH - JENSEN SPECIFIC 72910 WIRE TRANSFER 0 0 0 0 0 0 0 SAM'S NIGHT 1171207 1171207 WALT DISNEY WORLD EVENT 516972 516972 55561 32 1634715 1527851 106864 331629 3322894 3216030 106864 387190 387190 -280326 1 ANALYSIS GROUPCTAP 111 HUNTINGTON AVE 14TH FLOOR BOSTON MA 02199 042727260 C CORPORATION 40000 0 RESEARCH- SUPPORT OF COLLECTIVE ANALYSIS TRAJECTORY PROJECT ARKANSAS CHILDREN'S HOSPITAL 13 CHILDRENS WAY LITTLE ROCK AR 72202 710694931 501 (C) (3) 15000 0 RESEARCH- NEWBORN SCREENING ARKANSAS CHILDREN'S HOSPITAL 13 CHILDRENS WAY LITTLE ROCK AR 72202 710694931 501 (C) (3) 57603 0 RESEARCH- DORI EHR PROGRAM CINCINNATI CHILDREN'S HOSPITAL MC MLC 49003333 BURNET AVENUE CINCINNATI OH 45229 310833936 501 (C) (3) 25000 0 RESEARCH- NEWBORN SCREENING CINCINNATI CHILDREN'S HOSPITAL MC MLC 49003333 BURNET AVENUE CINCINNATI OH 45229 310833936 501 (C) (3) 617000 0 RESEARCH- ACTION NETWORK GRANT CRITICAL PATH 1730 E RIVER ROAD SUITE 200 TUCSON AZ 85718 201991334 501 (C) (3) 100000 0 RESEARCH - SUPPORT OF DUCHENNE REGULATORY SCIENCE CONSORTIUM NATIONWIDE CHILDREN'S HOSPITAL 700 CHILDRENS DR COLUMBUS OH 43205 316056230 501 (C) (3) 60000 0 RESEARCH - MEETING SUPPORT NORTHWESTERN UNIVERSITY 633 CLARK ROOM G-547 EVANSTON IL 60208 362167817 501 (C) (3) 73500 0 RESEARCH - WELLSTONE SUPPLEMENT NYU LANGONE HEALTH 350 FIRST AVE NEW YORK NY 10016 135562308 501 (C) (3) 200000 0 RESEARCH - GENE THERAPY NEW YORK UNIVERSITY ONE PARK AVE 5TH FLOOR NEW YORK NY 10016 135562308 501 (C) (3) 100000 0 RESEARCH - PEDIATRIC THERAPY MEDICAL ETHICS OHIO STATE UNIVERSITY 1960 KENNY ROAD COLUMBUS OH 43210 316025986 28236 0 RESEARCH - DIVERSITY EQUITY AND INCLUSION INTERVIEWS OHIO STATE UNIVERSITY 1960 KENNY ROAD COLUMBUS OH 43210 316025986 84363 0 RESEARCH - FELLOWSHIP OHIO STATE UNIVERSITY 1960 KENNY ROAD CINCINNATI OH 43210 316025986 19000 0 RESEARCH - NEWBORN SCREENING OHIO STATE UNIVERSITY 1960 KENNY ROAD CINCINNATI OH 43210 316025986 50000 0 RESEARCH - PATIENT PREFERENCE REGENTS OF THE UNIVERSITY OF CALIFORNIA - LA 1125 MURPHY HALL 405 HILGARD LOS ANGELES CA 90095 956006143 501 (C) (3) 10000 0 RESEARCH - DMD MOLECULAR AND CELLULAR DYNAMICS AT SINGLE NUCLEAR RESOLUTION REGENTS OF THE UNIVERSITY OF CALIFORNIA - LA 1125 MURPHY HALL 405 HILGARD LOS ANGELES CA 90095 956006143 501 (C) (3) 15000 0 RESEARCH - WELLSTONE SUPPLEMENT REGENTS OF UNIVERSITY OF MINNESOTA 2221 UNIVERSITY AVE SE STE 100 MINNEAPOLIS MN 55414 416007513 25000 0 RESEARCH - CLINICAL TRIALS THE UNIVERSITY OF IOWA 105 JESSUP HALL IOWA CITY IA 52242 426004813 25000 0 RESEARCH - DORI EHR PROGRAM UNIVERSITY OF CALIFORNIA BERKELEY 2195 HEARST AVE RM 130 BERKLEY CA 94720 946002123 501 (C) (3) 57690 0 RESEARCH - BIOMARKER UNIVERSITY OF COLORADO AT DENVER MAIL STOP F428 BLDG 500 13001 E 17TH PL AURORA CO 80045 846000555 50000 0 RESEARCH - DORI EHR PROGRAM UNIVERSITY OF FLORIDA 219 GRINTER HALL PO BOX 115500 GAINESVILLE FL 32611 596002052 501 (C) (3) 40000 0 RESEARCH - MEETING SUPPORT UNIVERSITY OF FLORIDA 219 GRINTER HALL PO BOX 115500 GAINESVILLE FL 32611 596002052 501 (C) (3) 178500 0 RESEARCH - WELLSTONE SUPPLEMENT UNIVERSITY OF FLORIDA FOUNDATION 1200 NEWELL DRIVE ARB R5-234 PO BOX 100267 GAINESVILLE FL 32610 590974739 501 (C) (3) 300000 0 RESEARCH - PRECLINICAL THERAPEUTIC ASSESSMENT LAB UNIVERSITY OF MASSACHUSETTS CHAN MED SCHOOL 55 LAKE AVE N WORCESTER MA 01655 043167352 20000 0 RESEARCH - NEWBORN SCREENING UNIVERSITY OF ROCHESTER MEDICAL CENTER 601 ELMWOOD AVE PO BOX 673 ROCHESTER NY 14642 160743209 210000 0 RESEARCH - NEWBORN SCREENING UNIVERISTY OF UTAH PRIMARY CHILDREN'S EHR 295 CHIPETA WAY SALT LAKE CITY UT 84158 876000525 501 (C) (3) 25163 0 RESEARCH - DORI EHR PROGRAM VANDERBILT 1211 MEDICAL CENTER DR NASHVILLE TN 37232 352525741 501 (C) (3) 10000 0 RESEARCH - NEWBORN SCREENING VIRGINIA TECH FOUNDATION 220 GILVERT ST BLACKSBURG VA 24061 540721690 501 (C) (3) 7500 0 RESEARCH - ROBOTICS THE NEMOURS FOUNDATION 1600 ROCKLAND ROAD WILMINGTON DE 19803 590634433 501 (C) (3) 7273 0 CARE PROGRAM - AWARD FOR MAINTAINING PPMD CERTIFIED DUCHENNE CARE CENTER STANDARDS PART I, LINE 2: THE ORGANIZATION HAS A STANDARDIZED GRANT TEMPLATE THAT REQUIRES REGULAR PERIODIC REPORTING OF THE USE OF GRANT FUNDS AND A PROGRESS REPORT OF THE GRANT ACTIVITIES. X X 0 0 0 0 0 0 0 0 0 PATRICIA A FURLONG PRESIDENT AND CEO 342375 0 27700 0 0 0 13662 0 32 0 383769 0 0 0 KAYLAN MOITOSO CHIEF BUSINESS OFFICER 271250 0 22400 0 0 0 8896 0 129 0 302675 0 0 0 RACHEL SCHRADER VICE PRESIDENT, CLINICAL CARE & EDUC 161800 0 13000 0 0 0 8800 0 24757 0 208357 0 0 0 JODI WOLFF CHIEF PROGRAM OFFICER 194569 0 0 0 0 0 9385 0 3010 0 206964 0 0 0 ANN MARTIN VICE PRESIDENT, COMMUNITY RESEARCH & 163600 0 13000 0 0 0 8888 0 7941 0 193429 0 0 0 X 6 580830 FMV ON DATE OF GIFT 0 1 0 FORM 990, PART VI, SECTION A, LINE 2 MICHELLE FURLONG - DIRECTOR IS THE DAUGHTER OF PATRICIA FURLONG CEO, OFFICER FORM 990, PART VI, SECTION A, LINE 8B NO COMMITTEE HAS AUTHORITY TO ACT ON BEHALF OF THE ENTIRE BOARD. FORM 990, PART VI, SECTION B, LINE 11B THE 990 IS COMPLETED BY AN INDEPENDENT CPA FIRM AND A DRAFT IS PRESENTED TO THE BOARD MEMBERS FOR REVIEW. THE BOARD THEN VOTES TO APPROVE THE 990 BEFORE IT IS SIGNED AND MAILED. IF THERE ARE ANY COMMENTS OR QUESTIONS THE ISSUE IS RESOLVED PRIOR TO FILING THE 990 WITH THE IRS. FORM 990, PART VI, SECTION B, LINE 12C THE SECRETARY IS RESPONSIBLE TO ENSURE EACH BOARD MEMBER HAS COMPLETED THEIR WRITTEN STATEMENT ANNUALLY. FORM 990, PART VI, SECTION B, LINE 15 PARENT PROJECT MUSCULAR DYSTROPHY CEO COMPENSATION REVIEW PROCESS THE PRESIDENT AND CEO IS THE PRINCIPAL REPRESENTATIVE OF THE PARENT PROJECT FOR MUSCULAR DYSTROPHY RESEARCH ("PPMD"), AND THE PERSON RESPONSIBLE FOR THE EFFICIENT OPERATION OF THE ORGANIZATION. THE ANNUAL PROCESS FOR DETERMINING HIS/HER COMPENSATION IS AS FOLLOWS: PPMD SHALL [EITHER THE FULL BOARD OR A COMPENSATION COMMITTEE/EXECUTIVE COMMITTEE] ANNUALLY EVALUATE THE PRESIDENT AND CEO ON HIS/HER PERFORMANCE, AND ASK FOR HIS/HER INPUT ON MATTERS OF PERFORMANCE AND COMPENSATION. BOARD APPROVAL. THE BOARD COMMITTEE WILL OBTAIN RESEARCH AND INFORMATION TO MAKE A RECOMMENDATION TO THE FULL BOARD FOR THE COMPENSATION (SALARY AND BENEFITS) OF THE PRESIDENT AND CEO BASED ON A REVIEW OF COMPARABILITY DATA. THIS DATA MAY INCLUDE THE FOLLOWING: - SALARY AND BENEFIT COMPENSATION STUDIES BY INDEPENDENT SOURCES; - WRITTEN JOB OFFERS FOR POSITIONS AT SIMILAR ORGANIZATIONS; - DOCUMENTED TELEPHONE CALLS ABOUT SIMILAR POSITIONS AT BOTH NONPROFIT AND FOR-PROFIT ORGANIZATIONS; AND - INFORMATION OBTAINED FROM THE IRS FORM 990 FILINGS OF SIMILAR ORGANIZATIONS. FORM 990, PART VI, SECTION C, LINE 19 AVAILABLE UPON REQUEST. FORM 990, PART IX, LINE 11G CONSULTANTS: PROGRAM SERVICE EXPENSES 1,146,523. MANAGEMENT AND GENERAL EXPENSES 174,370. FUNDRAISING EXPENSES 48,250. TOTAL EXPENSES 1,369,143. FORM 990, PART XII, LINE 2C THE PROCESS HAS NOT CHANGED FROM PRIOR YEAR.